Compare Biocon with FDC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs FDC - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON FDC BIOCON /
FDC
 
P/E (TTM) x 32.6 20.0 162.6% View Chart
P/BV x 3.9 3.9 100.2% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 BIOCON    FDC
EQUITY SHARE DATA
    BIOCON
Mar-19
FDC
Mar-18
BIOCON /
FDC
5-Yr Chart
Click to enlarge
High Rs707319 221.7%   
Low Rs554164 337.7%   
Sales per share (Unadj.) Rs91.961.6 149.1%  
Earnings per share (Unadj.) Rs16.79.9 168.0%  
Cash flow per share (Unadj.) Rs24.212.0 202.1%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs101.673.2 138.9%  
Shares outstanding (eoy) m600.00174.40 344.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x6.93.9 175.1%   
Avg P/E ratio x37.724.3 155.5%  
P/CF ratio (eoy) x26.120.2 129.2%  
Price / Book Value ratio x6.23.3 188.0%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m378,33042,118 898.3%   
No. of employees `0006.15.5 110.8%   
Total wages/salary Rs m11,6532,167 537.8%   
Avg. sales/employee Rs Th8,994.31,943.7 462.7%   
Avg. wages/employee Rs Th1,900.7391.7 485.2%   
Avg. net profit/employee Rs Th1,635.3313.7 521.3%   
INCOME DATA
Net Sales Rs m55,14410,751 512.9%  
Other income Rs m1,444510 283.4%   
Total revenues Rs m56,58811,260 502.5%   
Gross profit Rs m15,8832,267 700.6%  
Depreciation Rs m4,478351 1,274.3%   
Interest Rs m70914 5,064.3%   
Profit before tax Rs m12,1402,411 503.5%   
Minority Interest Rs m9-5 -187.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123671 316.3%   
Profit after tax Rs m10,0261,735 577.8%  
Gross profit margin %28.821.1 136.6%  
Effective tax rate %17.527.8 62.8%   
Net profit margin %18.216.1 112.7%  
BALANCE SHEET DATA
Current assets Rs m48,2287,213 668.7%   
Current liabilities Rs m30,3762,104 1,443.9%   
Net working cap to sales %32.447.5 68.1%  
Current ratio x1.63.4 46.3%  
Inventory Days Days6854 125.3%  
Debtors Days Days8628 308.4%  
Net fixed assets Rs m64,1306,865 934.2%   
Share capital Rs m3,000175 1,712.3%   
"Free" reserves Rs m57,98012,586 460.7%   
Net worth Rs m60,98012,761 477.9%   
Long term debt Rs m15,7666 262,766.7%   
Total assets Rs m121,92415,041 810.6%  
Interest coverage x18.1173.2 10.5%   
Debt to equity ratio x0.30 54,988.4%  
Sales to assets ratio x0.50.7 63.3%   
Return on assets %8.811.6 75.7%  
Return on equity %16.413.6 120.9%  
Return on capital %16.819.0 88.4%  
Exports to sales %28.112.3 227.8%   
Imports to sales %18.90-   
Exports (fob) Rs m15,5061,327 1,168.6%   
Imports (cif) Rs m10,399NA-   
Fx inflow Rs m15,5061,889 820.9%   
Fx outflow Rs m10,3990-   
Net fx Rs m5,1071,889 270.4%   
CASH FLOW
From Operations Rs m11,5461,498 770.6%  
From Investments Rs m-7,138201 -3,549.5%  
From Financial Activity Rs m-2,417-1,694 142.7%  
Net Cashflow Rs m2,10310 20,417.5%  

Share Holding

Indian Promoters % 40.4 68.9 58.6%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 4.7 178.7%  
FIIs % 10.7 7.5 142.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 19.0 104.7%  
Shareholders   109,995 23,730 463.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   WOCKHARDT  FULFORD INDIA  ORCHID PHARMA  DIVIS LABORATORIES  UNICHEM LAB  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

A Time Correction in the Nifty(Momentum Moves)

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Related Views on News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Mar 5, 2021 (Close)

TRACK BIOCON

BIOCON - LUPIN COMPARISON

COMPARE BIOCON WITH

MARKET STATS